In 2023, the cardiovascular system medicine sales in Germany stood at 5.86 billion USD and are projected to grow steadily from 2024 onwards. From 2023 to 2024, the market is anticipated to increase by 0.68%, reaching 5.9 billion USD. By 2028, the forecasted value is 6.06 billion USD, reflecting a compound annual growth rate (CAGR) of 0.84% over the five-year period.
Key future trends to watch for:
• Continuous innovation in cardiovascular treatments and medications likely driven by advancements in medical research and technology.
• Increasing incidence of cardiovascular diseases due to aging population, thus potentially driving demand further.
• Evolving healthcare policies and regulations, affecting market dynamics and pricing strategies.
